Cargando…

Colorectal Cancer Screening in Average Risk Populations: Evidence Summary

Introduction. The objectives of this systematic review were to evaluate the evidence for different CRC screening tests and to determine the most appropriate ages of initiation and cessation for CRC screening and the most appropriate screening intervals for selected CRC screening tests in people at a...

Descripción completa

Detalles Bibliográficos
Autores principales: Tinmouth, Jill, Vella, Emily T., Baxter, Nancy N., Dubé, Catherine, Gould, Michael, Hey, Amanda, Ismaila, Nofisat, McCurdy, Bronwen R., Paszat, Lawrence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5002289/
https://www.ncbi.nlm.nih.gov/pubmed/27597935
http://dx.doi.org/10.1155/2016/2878149
_version_ 1782450546546835456
author Tinmouth, Jill
Vella, Emily T.
Baxter, Nancy N.
Dubé, Catherine
Gould, Michael
Hey, Amanda
Ismaila, Nofisat
McCurdy, Bronwen R.
Paszat, Lawrence
author_facet Tinmouth, Jill
Vella, Emily T.
Baxter, Nancy N.
Dubé, Catherine
Gould, Michael
Hey, Amanda
Ismaila, Nofisat
McCurdy, Bronwen R.
Paszat, Lawrence
author_sort Tinmouth, Jill
collection PubMed
description Introduction. The objectives of this systematic review were to evaluate the evidence for different CRC screening tests and to determine the most appropriate ages of initiation and cessation for CRC screening and the most appropriate screening intervals for selected CRC screening tests in people at average risk for CRC. Methods. Electronic databases were searched for studies that addressed the research objectives. Meta-analyses were conducted with clinically homogenous trials. A working group reviewed the evidence to develop conclusions. Results. Thirty RCTs and 29 observational studies were included. Flexible sigmoidoscopy (FS) prevented CRC and led to the largest reduction in CRC mortality with a smaller but significant reduction in CRC mortality with the use of guaiac fecal occult blood tests (gFOBTs). There was insufficient or low quality evidence to support the use of other screening tests, including colonoscopy, as well as changing the ages of initiation and cessation for CRC screening with gFOBTs in Ontario. Either annual or biennial screening using gFOBT reduces CRC-related mortality. Conclusion. The evidentiary base supports the use of FS or FOBT (either annual or biennial) to screen patients at average risk for CRC. This work will guide the development of the provincial CRC screening program.
format Online
Article
Text
id pubmed-5002289
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-50022892016-09-05 Colorectal Cancer Screening in Average Risk Populations: Evidence Summary Tinmouth, Jill Vella, Emily T. Baxter, Nancy N. Dubé, Catherine Gould, Michael Hey, Amanda Ismaila, Nofisat McCurdy, Bronwen R. Paszat, Lawrence Can J Gastroenterol Hepatol Review Article Introduction. The objectives of this systematic review were to evaluate the evidence for different CRC screening tests and to determine the most appropriate ages of initiation and cessation for CRC screening and the most appropriate screening intervals for selected CRC screening tests in people at average risk for CRC. Methods. Electronic databases were searched for studies that addressed the research objectives. Meta-analyses were conducted with clinically homogenous trials. A working group reviewed the evidence to develop conclusions. Results. Thirty RCTs and 29 observational studies were included. Flexible sigmoidoscopy (FS) prevented CRC and led to the largest reduction in CRC mortality with a smaller but significant reduction in CRC mortality with the use of guaiac fecal occult blood tests (gFOBTs). There was insufficient or low quality evidence to support the use of other screening tests, including colonoscopy, as well as changing the ages of initiation and cessation for CRC screening with gFOBTs in Ontario. Either annual or biennial screening using gFOBT reduces CRC-related mortality. Conclusion. The evidentiary base supports the use of FS or FOBT (either annual or biennial) to screen patients at average risk for CRC. This work will guide the development of the provincial CRC screening program. Hindawi Publishing Corporation 2016 2016-08-14 /pmc/articles/PMC5002289/ /pubmed/27597935 http://dx.doi.org/10.1155/2016/2878149 Text en Copyright © 2016 Jill Tinmouth et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Tinmouth, Jill
Vella, Emily T.
Baxter, Nancy N.
Dubé, Catherine
Gould, Michael
Hey, Amanda
Ismaila, Nofisat
McCurdy, Bronwen R.
Paszat, Lawrence
Colorectal Cancer Screening in Average Risk Populations: Evidence Summary
title Colorectal Cancer Screening in Average Risk Populations: Evidence Summary
title_full Colorectal Cancer Screening in Average Risk Populations: Evidence Summary
title_fullStr Colorectal Cancer Screening in Average Risk Populations: Evidence Summary
title_full_unstemmed Colorectal Cancer Screening in Average Risk Populations: Evidence Summary
title_short Colorectal Cancer Screening in Average Risk Populations: Evidence Summary
title_sort colorectal cancer screening in average risk populations: evidence summary
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5002289/
https://www.ncbi.nlm.nih.gov/pubmed/27597935
http://dx.doi.org/10.1155/2016/2878149
work_keys_str_mv AT tinmouthjill colorectalcancerscreeninginaverageriskpopulationsevidencesummary
AT vellaemilyt colorectalcancerscreeninginaverageriskpopulationsevidencesummary
AT baxternancyn colorectalcancerscreeninginaverageriskpopulationsevidencesummary
AT dubecatherine colorectalcancerscreeninginaverageriskpopulationsevidencesummary
AT gouldmichael colorectalcancerscreeninginaverageriskpopulationsevidencesummary
AT heyamanda colorectalcancerscreeninginaverageriskpopulationsevidencesummary
AT ismailanofisat colorectalcancerscreeninginaverageriskpopulationsevidencesummary
AT mccurdybronwenr colorectalcancerscreeninginaverageriskpopulationsevidencesummary
AT paszatlawrence colorectalcancerscreeninginaverageriskpopulationsevidencesummary